Last Friday, Judge Matthew J. Kacsmaryk of the U.S. District of northern Texas issued a preliminary ruling invalidating the Food and Drug Administration’s approval of mifepristone, the drug used for more than half of all abortions in the U.S.
In a competing ruling, a federal district judge in Washington contradicted the order. While the abortion drug remains available, the stage is set for a Supreme Court review.
